This letter exposes some of the many reasons why microbiota modulation in patients with COVID-19 disease and more in general, in all people at greatest risk of contracting SARS-CoV2 virus infections, should be taken into consideration.
SARS-CoV-2 and microbiota / Schippa, Serena; Pantanella, Fabrizio. - In: JOURNAL OF PROBIOTICS & HEALTH. - ISSN 2329-8901. - 8:3(2020), pp. 1-3. [10.4172/2329-8901.1000217]
SARS-CoV-2 and microbiota
Serena SchippaPrimo
;Fabrizio PantanellaUltimo
2020
Abstract
This letter exposes some of the many reasons why microbiota modulation in patients with COVID-19 disease and more in general, in all people at greatest risk of contracting SARS-CoV2 virus infections, should be taken into consideration.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Schippa_SARS-CoV-2_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
139.04 kB
Formato
Adobe PDF
|
139.04 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
